The sort of Ki-ras codon 12 mutation in tumours was aspartic acid (67%), valine (22%) and cysteine (11%) with pancreatic cancer patients, and aspartic acid (50%) and valine (50%) with colorectal cancer patients. This evidence concerns the gene KRAS and familial pancreatic carcinoma.